Crossmark

Association between autoimmune diseases and COVID-19 as assessed in both a test-negative case–control and population case–control design

Crossref DOI link: https://doi.org/10.1186/s13317-020-00141-1

Published Online: 2020-10-06

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Murtas, Rossella

Andreano, Anita

Gervasi, Federico

Guido, Davide

Consolazio, David

Tunesi, Sara

Andreoni, Laura

Greco, Maria Teresa

Gattoni, Maria Elena

Sandrini, Monica

Riussi, Antonio

Russo, Antonio Giampiero https://orcid.org/0000-0002-5681-5861
License Information

Text and Data Mining valid from 2020-10-06

Version of Record valid from 2020-10-06
More Information

Article History

Received: 24 July 2020

Accepted: 17 September 2020

First Online: 6 October 2020

Ethics approval and consent to participate

: Ethics approval and consent to participate were not required, as this is an observational study based on data routinely collected by the Agency for Health Protection (ATS) of Milan, a public body of the Regional Health Service-Lombardy Region. The ATS has among its institutional functions, established by the Lombardy Region legislation (R.L. 23/2015), the government of the care pathway at the individual level in the regional social and healthcare system, the evaluation of the services provided to, and the outcomes of, patients residing in the covered area. This study is also ethically compliant with the National Law (D.Lgs. 101/2018) and the “General Authorisation to Process Personal Data for Scientific Research Purposes” (n.8 and 9/2016, referred to in the Data Protection Authority action of 13/12/2018). Data were anonymized with a unique identifier in the different datasets before being used for the analyses.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below